| Literature DB >> 27486334 |
Min Yu1, Yuan Meng2, Bin Xu2, Lin Zhao3, Qingfu Zhang4.
Abstract
Micronodular thymoma (MNT) with lymphoid stroma is a rare thymic epithelial neoplasm with the characteristics of multiple nodules separated by abundant lymphoid stroma. MNTs mainly arise in the anterior mediastinum and thymus, while ectopic MNTs are extremely rarely seen. Here, we report an ectopic MNT that occurred in the neck of a 62-year-old woman. There were also scattered eosinophilic granulocytes and S100(+)/CD1a(+) Langerhans cells within the tumor. This case provides a better understanding of such rare, poorly understood cases.Entities:
Keywords: Langerhans cell; ectopic; lymphoid stroma; micronodular thymoma
Year: 2016 PMID: 27486334 PMCID: PMC4958359 DOI: 10.2147/OTT.S110802
Source DB: PubMed Journal: Onco Targets Ther ISSN: 1178-6930 Impact factor: 4.147
Figure 1Cervical CT image.
Note: Cervical CT showed several inhomogeneous nodules (indicated by the arrows) near the cervical vessels.
Abbreviation: CT, computed tomography.
Figure 2Hematoxylin and eosin staining of the thymoma.
Notes: (A) Tumor cells were arranged in a nodular pattern. The infiltrated stroma contained large numbers of lymphocytes with formation of lymphoid follicles. Scale bar is 800 μm. (Original magnification ×100.) (B) Epithelial tumor cells were oval shaped with occasionally atypia or mitotic activity. Scale bar is 300 μm. (Original magnification ×200.) (C) Eosinophilic granulocytes infiltrated the tumor nodules and the surrounding stroma. Scale bar is 300 μm. (Original magnification ×200.) (D) High magnification showed the infiltrated eosinophilic granulocytes and the proliferating LCs. Nuclear grooves (indicated by the arrow) could be observed in some LCs. Scale bar is 100 μm. (Original magnification ×100.)
Abbreviation: LCs, Langerhans cells.
Immunohistochemical staining reagents of the eMNT
| Antibody | Clone | Source | Dilution | Results |
|---|---|---|---|---|
| CK (pan) | AE1/AE3 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | + |
| CK5/6 | D5/16B4 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | + |
| CK7 | OV-TL 12/30 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | − |
| CK20 | Ks20.8 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | Tumor cells−, lymphocyte+ |
| CD1a | O10 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | LCs+ |
| CD3 | SP7 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | T lymphocyte+ |
| CD5 | SP19 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | T lymphocyte+ |
| CD20 | L26 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | B lymphocyte+ |
| CD21 | EP3093 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | Follicular dendritic cells+ |
| CD68 | KP1 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | Tissue cells+ |
| Ki-67 | MIB-1 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | 10% |
| P63 | MX013 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | + |
| Pax-5 | SP34 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | B lymphocyte+ |
| S100 | 4C4.9 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | LCs+ |
| TdT | MX010 | Fuzhou Maixin Biology, Fuzhou, People’s Republic of China | Ready to use | Immature T lymphocytes+ |
Abbreviations: eMNT, ectopic micronodular thymoma; LCs, Langerhans cells.
Figure 3Immunohistochemical staining of the thymoma.
Notes: Proliferation of epithelial tumor cells were stained by CK (pan) (A), CK5/6 (B), and P63 (C). Proliferated LCs were positive for CD1a (D) and S100 (E). Mature B lymphocytes were positive for Pax-5 (F). Scale bar is 800 μm. (Original magnification ×100.)
Abbreviation: LCs, Langerhans cells.
Cases of micronodular thymic neoplasm reported in literature
| First author | Year | Case | Sex (n) | Age (years) | Site | Size (cm) | Masaoka stage | Manufacture | Follow-up case | Follow-up duration (month) | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Suster and Moran | 1999 | 17 | M10/F7 | 41–76 | Thymus | 3–10 | I–IV | One with tuberculosis; one with anemia; one with splenauxe | 8 | 12–84 | Alive |
| Tateyama et al | 2001 | 9 | M5/F6 | 56–73 | Thymus | NA | I–III | One with MG; two with HG; two with eyelidptosis, CP, fever | 9 | 18–180 | Seven cases alive; one case died of esophagus cancer; one case died of rectal cancer |
| Pan et al | 2001 | 5 | M4/F1 | 69–80 | Thymus | 2.5–7 | I–II | Two with MG | NA | NA | NA |
| Thomas et al | 2002 | 6 | NA | NA | Thymus | NA | I–II | NA | NA | NA | NA |
| Mende et al | 2004 | 1 | M | 45 | Neck | 3.5 | I | None | 1 | 12 | Alive |
| Mourra et al | 2005 | 1 | F | 68 | Neck | 1.2 | I | None | NA | NA | NA |
| Ströbel et al | 2005 | 18 | M11/F7 | 47–79 | Thymus | NA | I–II | One with MG | 17 | 24–190 | Alive |
| Rieker et al | 2005 | 1 | F | 80 | Thymus | 7 | I | Hypertension, DM | 1 | 0 | Died of cardiac failure on the second day |
| El et al | 2006 | 2 | M1/F1 | 62–64 | Thymus | 7–8 | I–II | Two with CP | 2 | 17–24 | Alive |
| Tahara et al | 2012 | 1 | M | 56 | Thymus | NA | NA | NA | NA | NA | NA |
| Kim et al | 2013 | 1 | M | 73 | Thymus | 5.1 | I | CP | 1 | 12 | Alive |
| Zhu et al | 2014 | 1 | F | 76 | Neck | 3.7 | I | None | 1 | 24 | Alive |
| Mneimneh et al | 2015 | 9 | M4/F5 | 51–83 | Thymus | 3–8.5 | I–III | One with hypothyroidism, facial paralysis; one with MGUS lytic lesion of skull; one with lung adenocarcinoma; one with hypertension; one with ulcerative colitis | 4 | 0–72 | Alive |
| Ishikawa et al | 2015 | 6 | M4/F2 | 56–74 | Thymus | 1.2–5 | I–IIa | None | 6 | 36–93 | Alive |
| Chen et al | 2015 | 1 | M | 79 | Thymus | 10.7 | IIa | None | 1 | 6 | Alive |
| Cha et al | 2015 | 1 | M | 63 | Thymus | 7 | I | None | NA | NA | NA |
| Present study | 1 | F | 62 | Neck | Biopsy | I | None | 1 | 4 | Alive |
Abbreviations: CP, chest pain; DM, diabetes mellitus; HG, hypogammaglobulinaemia; MG, myasthenia gravis; MGUS, monoclonal gammopathy of unknown significance; NA, not available; M, male; F, female.